健康中国志愿者中[123I]碘氟潘的安全性、生物分布与辐射剂量学
8名中国健康志愿者接受单次111 MBq ± 10%的[123I]碘氟潘注射,进行全身平面显像、脑SPECT及药代动力学分析,并与欧洲研究比较。结果显示摄取和生物分布与欧洲研究高度相似,排泄主要经肾,脑内摄取在注射后3至6小时稳定,有效剂量差异无临床意义,药物耐受良好。
要点
- 单次111 MBq ± 10%的[123I]碘氟潘注射在中国健康志愿者中安全且耐受良好。
- 注射后3至6小时的SPECT显像窗口在中国受试者中是合适的。
- 中国与欧洲健康志愿者的平均有效剂量差异无临床意义。
核心结论
- 单次111 MBq ± 10%的[123I]碘氟潘注射是安全的且耐受良好。
- 注射后3至6小时的SPECT显像窗口在中国受试者中是合适的。
研究设计与样本
- 8名中国健康志愿者接受单次111 MBq ± 10%的[123I]碘氟潘注射。
- 在注射后10分钟及1、2、4、5、24和48小时进行全身(头至大腿中部)前后位平面闪烁显像。
- 采用Cristy-Eckerman女性和雌雄同体男性模体评估剂量学。
- 注射后3和6小时采集脑SPECT图像。
- 收集48小时内的血样和全部尿液进行药代动力学分析。
主要发现
- 中国与欧洲研究的摄取和生物分布高度相似。
- 排泄主要经肾,前5小时数值相似,之后出现差异,可能由于受试者身高和体重差异。
- 脑内感兴趣区的示踪剂摄取在3至6小时显像窗口内稳定。
- 中国健康志愿者与欧洲健康志愿者的平均有效剂量分别为0.028 ± 0.00448 mSv/MBq和0.023 ± 0.00152 mSv/MBq,差异无临床意义。
- [123I]碘氟潘耐受良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: [123I]ioflupane is a radiopharmaceutical used to visualise the dopaminergic neuron terminals in the striata, to aid in the differential diagnosis among Parkinsonian syndromes (e.g., Parkinson's disease). However, nearly all of the subjects in the initial development studies of [123I]ioflupane were Caucasian. METHODS: 8 Chinese healthy volunteers (HVs) received a single 111 MBq ± 10% dose of [123I]ioflupane and had simultaneous whole-body (head to mid-thigh) anterior and posterior planar scintigraphy scans at 10 min and 1, 2, 4, 5, 24, and 48 h. To estimate biodistribution, dosimetry was evaluated for the Cristy-Eckerman female and hermaphrodite male phantoms. Single-photon emission computed tomography (SPECT) images of the brain were acquired at 3 and 6 h after injection. Blood samples and all voided urine were collected for 48 h for pharmacokinetic analysis. The results were then compared with those of a similar European study. RESULTS: There were strong similarities in uptake and biodistribution between the Chinese and European studies. Excretion was primarily renal, and the values were similar for the first 5 h but diverged after that, possibly because of differences in subjects' height and weight. Tracer uptake in regions of interest in the brain was stable over the imaging window of 3 to 6 h. The difference in mean effective dose for Chinese HVs vs European HVs (0.028 ± 0.00448 vs 0.023 ± 0.00152 mSv/MBq) was not clinically significant. The [123I]ioflupane was well tolerated. CONCLUSION: This study demonstrated that a single 111 MBq ± 10% dose of [123I]ioflupane injection was safe and well tolerated, and the SPECT imaging window of 3 to 6 h after injection of [123I]ioflupane was appropriate in Chinese subjects. Trial registration number ClinicalTrials.gov: NCT04564092.
引用
- Zhang M, Wang Y, Wang J, et al. Safety, biodistribution and radiation dosimetry of [123I]ioflupane in healthy Chinese volunteers. EJNMMI Res. 2023. PMID: 37029298. doi:10.1186/s13550-023-00978-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。